InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,425.20
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.35
(
-0.29%
)
Bitcoin
63,930.63
(
-0.53%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

$heff

Send PM Follow Ignore
Followers 3420
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

$heff

Re: $heff post# 83692

Tuesday, 10/21/2014 11:20:34 PM

Tuesday, October 21, 2014 11:20:34 PM

Post# of 97239
$VRTX..$110 (AH) Vertex Pharm confirms that FDA Advisory Committee recommends approval of KALYDECO (ivacaftor) for use in people with Cystic Fibrosis ages 6 and older who have the R117H mutation.

Sheff's Station...All Aboard...Sign Up Here!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up